Skip to main content

Graft-versus-Host Disease

  • Chapter
Deadly Dermatologic Diseases
  • 877 Accesses

Abstract

GVHD is a common consequence of allogeneic bone marrow transplantation. Approximately 3 weeks following complete marrow eradication and the transplantation of allogeneic donor marrow cells, a cutaneous eruption is seen in up to 20% to 80% of patients, and may result in the death of the patient (1,2). The cutaneous manifestations may be the first indication of evolving GVHD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD. Bone marrow transplantation. N Eng J Med 1975; 292: 832–843, 895—902.

    Article  CAS  Google Scholar 

  2. Deeg HJ, Storb R. Graft-versus-host disease: Pathophysiological and clinical aspects. Ann Rev Med 1984; 35: 11–24.

    Article  PubMed  CAS  Google Scholar 

  3. Anderson KC, Weinstein HJ. Transfusion-associated graft-vs.-host disease. N Eng J Med 1990; 323: 315–321.

    Article  CAS  Google Scholar 

  4. Billingham RE. The biology of graft-versus-host reactions. Harvey Lect 1966–67; 62: 21–78.

    PubMed  Google Scholar 

  5. Bauer DJ, Hood AF, Horn TD. Histologic comparison of autologous graft-vs.-host reaction and cutaneous eruption of lymphocyte recovery. Arch Dermatol 1993; 129: 855–858.

    Article  PubMed  CAS  Google Scholar 

  6. Zhou Y, Barnett MJ, Rivers JK. Clinical significance of skin biopsies in the diagnosis and management of graft-vs.-host disease in early postallogeneic bone marrow transplantation. Arch Dermatol 2000; 136: 717–721.

    Article  PubMed  CAS  Google Scholar 

  7. Storb R, Prentice RL, Buckner CD, Clift RA, Appelbaum F, Deeg J, Doney K, Hansen JA, Mason M, Sanders JE, Singer J, Sullivan KM, Witherspoon RP, Thomas ED. Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings: Beneficial effect of a protective environment. N Eng J Med 1983; 308: 302–307.

    Article  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

(2007). Graft-versus-Host Disease. In: Deadly Dermatologic Diseases. Springer, New York, NY. https://doi.org/10.1007/978-0-387-68858-9_32

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-68858-9_32

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-25442-5

  • Online ISBN: 978-0-387-68858-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics